The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants: Letter Report
WHO (World Health Organization). 1996. Investing in health research and development, Reportof the ad hoc committee on health research relating to future intervention options. Geneva, Switzerland: World Health Organization.
WHO. 2003. Position of WHO’s Roll Back Malaria Department on malaria treatment policy. Geneva, Switzerland: World Health Organization.
WHO. 2004a. A strategic framework for malaria prevention and control during pregnancy in theAfrica region. Brazzaville: WHO Regional Office for Africa.
WHO. 2004b. Hepatitis b vaccines. Wkly Epidemiol Rec 79(28):255-263. Geneva, Switzerland: World Health Organization.
WHO. 2006. WHO advisory committee on serological responses to expanded programme onimmunization vaccines in infants receiving Intermittent Preventive Treatment for malaria (IPTi). Geneva, Switzerland: World Health Organization.
WHO. 2008b. Report of the Technical Expert Group (TEG) meeting on intermittent preventivetherapy in infancy (IPTi), Geneva, 8-10 October 2007. Geneva, Switzerland: World Health Organization.
WHO/CHD (World Health Organization/Division of Child Health and Development). 1998. Randomised trial to assess benefits and safety of vitamin A supplementation linked to immunisation in early infancy. Lancet 352(9136):1257-1263.
Zou, G. 2004. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7): 702-706.